“…To date, MeHg has been shown to possess high affinity for tubulin sulfhydryl groups (Vogel et al, 1985), to depolymerize cerebral microtubules in vitro (Abe et al, 1975) and to directly inhibit in vitro microtubule assembly (Sager et al, 1983). Moreover, MeHg has been reported to promote microtubule disruption in several cell models, including human fibroblasts (Sager et al, 1983), mouse splenic lymphocytes (Roy et al, 1991), neuroblastoma (Prasad et al, 1979), glioma cells (Prasad et al, 1979;Miura et al, 1984) and embryonal carcinoma cells Wasteneys et al, 1988;Graff et al, 1993). Evidence supporting a role for cytoskeletal alterations and microtubule disruption in the onset of CGC apoptosis has been recently provided by Bonfoco et al (1995a), whose results indicated that an initial cytoskeletal damage, such as that caused by a microtubule disrupting agent, is sufficient to trigger the apoptotic degeneration of these neurons (Bonfoco et al, 1995a).…”